Related content

Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization–embryo transfer

By Doldi Nicola   Persico Paola   Di Sebastiano Francesca   Marsiglio Elena   Ferrari Augusto  

Gynecological Endocrinology, Vol. 22, Iss. 5, 2006-05 ,pp. : 235-238

Informa Healthcare

Access to resources Recommend Favorite

Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles

By Seow Kok-Min   Lin Yu-Hung   Huang Lee-Win   Hsieh Bih-Chwen   Huang Shih-Chia   Chen Chin-Yu   Chen Pei-Hsin   Tzeng Chii-Ruey   Hwang Jiann-Loong  

Gynecological Endocrinology, Vol. 23, Iss. 6, 2007-06 ,pp. : 338-342

Informa Healthcare

Access to resources Recommend Favorite

Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?

By Lin Y  

Human Reproduction, Vol. 14, Iss. 4, 1999-04 ,pp. : 885-888

Oxford University Press

Access to resources Recommend Favorite

Bone resorption starts at 14 days of treatment with gonadotropin-releasing hormone agonist in in vitro fertilization cycles

By Yilmaz H   Ozgur K   Isikoglu M   Sonmez C   Uner M  

Gynecological Endocrinology, Vol. 19, Iss. 1, 2004-07 ,pp. : 40-46

Informa Healthcare

Access to resources Recommend Favorite

Relationship between gonadotropin releasing hormone agonist dosage and in vitro fertilization outcome

By Lorusso F.   Depalo R.   Selvaggi L.  

Gynecological Endocrinology, Vol. 18, Iss. 2, 2004-01 ,pp. : 69-73

Informa Healthcare

Access to resources Recommend Favorite